Lophius Biosciences

The German firm has signed a deal for BL&H to distribute, market, and sell its T-Track CMV kit in South Korea once it is approved as an in vitro diagnostic.

NEW YORK (GenomeWeb) – Lophius Biosciences today announced it received a €2.0 million ($2.8 million) investment to fund clinical studies of its flagship product and to develop new products.
The firm also announced a new CEO and changes to its board.

NEW YORK (GenomeWeb News) – Lophius Biosciences today said that it has joined a research consortium that will work with the firm on developing its T-Track MS diagnostic test for initial diagnosis of multiples sclerosis and monitoring of disease progression.

NEW YORK (GenomeWeb News) – Oxford Immunotec and Lophius Biosciences said today that they have signed agreements providing each other access to certain intellectual property.

NEW YORK (GenomeWeb News) – T-cell-based diagnostics development firm Lophius Biosciences today announced the closing of a financing round that brought in €4 million ($5.3 million) in funding.

Pairings

Premium

Karl Kleine, Kornelia Schlombs, Noah Nasser, Suzanne Yokota, Xitong Li

People in the News

Premium

Noah Nasser, Suzanne Yokota, Xitong Li, Karl Kleine, Kornelia Schlombs

The German startup is developing T-cell-based diagnostics and also provides cell-based assay testing for pharmaceuticals.

An Australian-led team has generated a draft genome assembly of the invasive cane toad in hopes it will help in population control, the Sydney Morning Herald reports.

The New York Times reports that the US Department of Defense has implemented about half the recommendations made to improve safe handling of dangerous agents.

In PLOS this week: approach for teasing out archaic introgression in human genomes, immune transcription features in HCV infection, and more.

Stat News reports that Maryland is promoting itself to the biotech industry with a mobile billboard.